Source: International Congress 2015 – COPD: notable points
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Evgenia A. Kochetkova (Strasbourg, France), Ludmila Ugay, Evgenia Kochetkova, Vera Nevzorova. Serum leptin, adponectin and its tissue expression in COPD patients with osteopenic syndrome. Eur Respir J 2015; 46: Suppl. 59, 4794

Member's Comments

No comment yet.

Related content which might interest you: Plasma osteoprotegerin is related to femoral osteoporosis in patients with COPD Source: Annual Congress 2013 –COPD mechanisms Year: 2013 Serum levels of leptin and visfatin in chronic obstructive pulmonary disease Source: International Congress 2015 – Different data in COPD Year: 2015 Serum IL-17 and IL-18 levels in asthma-COPD overlap syndrome patients Source: International Congress 2015 – Promising novel findings in translational pulmonary research Year: 2015 Osteoporosis and adipose tissue expression of adipokines and osteoprotegerin in severe chronic obstructive pulmonary disease Source: Annual Congress 2013 –COPD: acute exacerbations and others Year: 2013 Plasma levels of TIPM-2 in patients with COPD Source: International Congress 2016 – Molecular targets in pulmonary disease Year: 2016 Plasma surfactant protein D (SP-D) and nutritive status in patients with COPD Source: Annual Congress 2013 –COPD treatment and others Year: 2013 Increased total serum levels of ghrelin and nesfatin in chronic obstructive pulmonary disease Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD Year: 2015 Analysis of serum prohepcidin and hepcidin levels in COPD patients by stages and by patient cathegory Source: Annual Congress 2013 –COPD treatment Year: 2013 Elevated circulating CTLA-4 level in patients with COPD is related to systemic inflammation and disease severity Source: Annual Congress 2013 –COPD: markers and inflammation Year: 2013 Increased serum level of apelin in chronic obstructive pulmonary disease Source: International Congress 2015 – COPD: interesting notes Year: 2015 Alterations in gene expression of RAGE and its sheddases in blood of COPD patients do not relate to decreased plasma (e)sRAGE levels Source: International Congress 2014 – Mechanisms of COPD and inhalation injury Year: 2014 Serum levels of RAAS components in COPD Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease Year: 2015 Cytokines and MMP-9 level in serum and induced sputum of patients with suspicion of occupational COPD Source: International Congress 2016 – Occupational and environmental exposures and biomarkers: human studies, animal data, and in vitro methods Year: 2016 TNF-α, IL-6, IL-10 serum activity in patients with obesity-associated arterial hypertension depend on bronchial obstruction presence Source: International Congress 2015 – The immunology of allergic airway disease Year: 2015 Metabolic syndrome in patients with COPD and their association with systemic inflammation Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease Year: 2015 Serum leptin levels in patients with chronic airway diseases Source: Eur Respir J 2005; 26: Suppl. 49, 306s Year: 2005 Inflammatory markers (IL-6, suPAR) and arterial stiffness parameters in COPD patients Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016 Increased oxidative stress in patients with chronic obstructive pulmonary disease (COPD) and metabolic syndrome (MetS) Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench Year: 2013 The relationship between systemic inflammation and vitamin D levels in COPD Source: Annual Congress 2013 –Factors associated with outcomes in COPD Year: 2013 Association of angiopoietin-like protein 4 with cardiovascular function in patients with COPD Source: International Congress 2016 – Recent high impact findings regarding COPD comorbidities Year: 2016